Vandana Singh
·
July 9, 2025
Benzinga
Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.
read more
September 19, 2025
September 5, 2025
July 25, 2025
Barchart
July 15, 2025
July 5, 2025
Bloomberg